InvestorsHub Logo
Followers 148
Posts 7871
Boards Moderated 2
Alias Born 03/15/2002

Re: Princess17 post# 3423

Tuesday, 03/31/2020 1:00:43 PM

Tuesday, March 31, 2020 1:00:43 PM

Post# of 3562
12:25 PM EDT, 03/31/2020 (MT Newswires) -- Teva Pharmaceutical (TEVA) was up almost 9.5% Tuesday as the US Patent and Trademark Office's Patent Trial and Appeal Board upheld three of the company's patents over a migraine treatment and rejected Eli Lilly's (LLY) claim that the patents are invalid, Bloomberg News reported Tuesday.
Lilly alleged that calcitonin gene-related peptide which is linked to migraines, was targeted for treating the condition before Teva filed its patent applications, Bloomberg reported.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News